−  Takeda UK Ltd. is pleased to announce that NICE has recommended the use of   Takhzyro®  (lanadelumab)  subcutaneous injection as an option for preventing  recurrent attacks of hereditary angioedema …

source https://finance.yahoo.com/news/nice-recommends-takhzyro-lanadelumab-treatment-083000344.html?.tsrc=rss